The Oncology Institute, Inc. TOI Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price?
- The Oncology Institute, Inc. (TOI) reported share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price of $2.26 in Q1 2026.
- How has The Oncology Institute, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price changed year-over-year?
- The Oncology Institute, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price increased by 34.5% year-over-year, from $1.68 to $2.26.
- What is the long-term trend for The Oncology Institute, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price?
- Over 4 years (2021 to 2025), The Oncology Institute, Inc.'s share-based compensation arrangement by share-based payment award, options, outstanding, weighted average exercise price has grown at a 25.8% compound annual growth rate (CAGR), from $0.89 to $2.23.